Cognitive Reserve on Pain Catastrophizing and Cognitive Function in Geriatric Patients With Chronic Pain

Sponsor

Ahram Canadian University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05933564

Collaborator

(none)

110

Enrollment

Location

Anticipated Duration (Months)

18.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To investigate the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain, and to explore whether cognitive reserve moderates the relationship between pain catastrophizing and cognitive function.

Condition or Disease	Intervention/Treatment	Phase
Chronic Pain	Other: No intervention (cross-sectional study)

Study Design

Study Type:

Observational

Anticipated Enrollment :

110 participants

Observational Model:

Family-Based

Time Perspective:

Cross-Sectional

Official Title:

The Association Between Cognitive Reserve, Pain Catastrophizing, and Cognitive Function in Geriatric Patients With Chronic Pain: A Cross-sectional Study

Anticipated Study Start Date :

Jun 30, 2023

Anticipated Primary Completion Date :

Dec 30, 2023

Anticipated Study Completion Date :

Dec 30, 2023

Arms and Interventions

Arm	Intervention/Treatment
Chronic Pain Patients with Varying Cognitive Reserve Community-dwelling adults aged 65-85 years with chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions.	Other: No intervention (cross-sectional study) This is a cross-sectional study examining the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain; no intervention is being implemented or tested.

Arm

Intervention/Treatment

Chronic Pain Patients with Varying Cognitive Reserve

Community-dwelling adults aged 65-85 years with chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions.

Other: No intervention (cross-sectional study)

This is a cross-sectional study examining the association between cognitive reserve, pain catastrophizing, and cognitive function in geriatric patients with chronic pain; no intervention is being implemented or tested.

Outcome Measures

Primary Outcome Measures

Association between pain catastrophizing and cognitive function [Baseline assessment]
he relationship between pain catastrophizing, as measured by the Pain Catastrophizing Scale (PCS), and cognitive function, as measured by the Montreal Cognitive Assessment (MoCA version 7.1).

Secondary Outcome Measures

Moderating effect of cognitive reserve on the association between pain catastrophizing and cognitive function [Baseline assessment]
Investigate whether cognitive reserve, as measured by the Cognitive Reserve Index Questionnaire (CRIq), moderates the relationship between pain catastrophizing (PCS) and cognitive function (MoCA version 7.1).

Eligibility Criteria

Criteria

Ages Eligible for Study:

65 Years to 85 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Aged 65 to 85 years
Experiencing chronic pain (≥3 months) attributable to osteoarthritis or neuropathic conditions
Able to read, write, and speak the language in which assessments are administered
Willing and able to provide informed consent

Exclusion Criteria:

Diagnosed with a neurodegenerative disorder (e.g., Alzheimer's disease, Parkinson's disease)
History of significant head injury, stroke, or brain tumor
Current substance abuse or dependence
Severe psychiatric illness (e.g., schizophrenia, bipolar disorder)
Significant sensory or motor impairments that may interfere with the ability to complete assessments

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Outpatient clinic of faculty of physical therapy, Ahram Canadian University	Al Ḩayy Ath Thāmin	Giza	Egypt	3221405

Sponsors and Collaborators

Ahram Canadian University

Investigators

Study Director: Amal Fawzy, Ph.d, Faculty of Physical Therapy, Ahram Canadian University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Mohamed Magdy ElMeligie, Lecturer of Physical Therapy and Director of Electromyography Lab, Ahram Canadian University

ClinicalTrials.gov Identifier:

NCT05933564

Other Study ID Numbers:

012/20265888

First Posted:

Jul 6, 2023

Last Update Posted:

Jul 6, 2023

Last Verified:

Jun 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Chronic Pain

Study Results

No Results Posted as of Jul 6, 2023